Skip to main content

Table 2 Healthcare use in MCRC patients receiving XELOX or FOLFOX4

From: Cost-analysis of XELOX and FOLFOX4 for treatment of colorectal cancer to assist decision-making on reimbursement

  XELOX
(n = 30)
Mean no./person (SD)
FOLFOX4
(n = 30)
Mean no./person (SD)
Chemotherapy cycles 7.3 (1.4) 9.2 (2.8)
Other drugs 9.3 (5.8) 12.4 (7.2)
Hospital bed-days 10.3 (5.2) 33.2 (9.1)
Outpatient clinic visits 15.5 (3.4) 16.5 (5.1)
Laboratory investigations 38.6 (11.2) 37.3 (12.8)
X-rays and scans 4.3 (3.1) 3.8 (2.5)